Lipid risk factors and the regression of atherosclerosis

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Angiographically monitored clinical trials of antilipidemic therapy have demonstrated that the progression of atherosclerosis may be slowed or even reversed. The clinical benefit observed in these trials strengthens the rationale for aggressive therapy in patients with known atherosclerotic disease. Additionally, these trials have provided further insight on the basis of clinical events and the risk factors associated with progression.

Original languageEnglish (US)
JournalThe American Journal of Cardiology
Volume76
Issue number1-2 SUPPL. 1
DOIs
StatePublished - Jul 13 1995

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Lipid risk factors and the regression of atherosclerosis'. Together they form a unique fingerprint.

Cite this